O. Un, était pratiqué pour tous les patients par le modèle Cirrus (Carl Zeiss Meditec, Dublin, California) afin d'obtenir l'épaisseur maculaire moyenne des 1 mm centraux (EMM)

. Dans-le-groupe-connu-pour-présenter-un-gpao-ou-un-glaucome-uvéitique, la PIO s'est élevée 3 fois plus que dans le groupe ne présentant pas d

O. Durrani, N. Tehrani, J. Marr, P. Moradi, P. Stavrou et al., Degree, duration, and causes of visual loss in uveitis, British Journal of Ophthalmology, vol.88, issue.9, pp.1159-62, 2004.
DOI : 10.1136/bjo.2003.037226

A. Brézin and . Les-uvéites, Rapport de la Société Française d'Ophtalmologie, 2010.

M. Suttorp-schulten and A. Rothova, The possible impact of uveitis in blindness: a literature survey., British Journal of Ophthalmology, vol.80, issue.9, pp.844-852, 1996.
DOI : 10.1136/bjo.80.9.844

D. Smet, M. Okada, and A. , Cystoid Macular Edema in Uveitis, Dev Ophthalmol, vol.47, pp.136-183, 2010.
DOI : 10.1159/000320077

N. Saraiya and D. Goldstein, Dexamethasone for ocular inflammation, Expert Opinion on Pharmacotherapy, vol.124, issue.7, pp.1127-1158, 2011.
DOI : 10.1001/archopht.125.11.ecs70063

S. Scholl, A. A. Loewenstein, A. Rizzo, S. Kupperman, and B. , General pathophysiology of macular edema, European Journal of Ophthalmology, vol.21, issue.Suppl. 6, pp.10-19, 2011.
DOI : 10.5301/EJO.2010.6050

M. Weber, Rétine -Inflammation, 2012.

F. Behar-cohen, L. Kowalczuk, N. Keller, M. Savoldelli, F. Azan et al., Anatomie de la r??tine, EMC - Ophtalmologie, vol.6, issue.1, pp.1-14, 2009.
DOI : 10.1016/S0246-0343(09)30048-9

D. Gaucher and A. Gaudric, Oedème maculaire (hors diabète), EMC -Ophtalmol, vol.11, issue.2, pp.1-21, 2014.

G. Caputo and M. Hartnett, Société française d'ophtalmologie. Décollements de rétine rapport 2011, 2011.

M. Nentwich and M. Ulbig, The Therapeutic Potential of Intraocular Depot Steroid Systems. Dtsch Ärztebl Int, pp.584-90, 2012.

E. Newman and A. Reichenbach, The M??ller cell: a functional element of the retina, Trends in Neurosciences, vol.19, issue.8, pp.307-319, 1996.
DOI : 10.1016/0166-2236(96)10040-0

X. Liu, H. Kobayashi, Z. Jin, A. Wada, and . Nao-i-n, Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat, Mol Vis, vol.13, pp.309-326, 2007.

A. Bringmann, A. Reichenbach, and P. Wiedemann, Pathomechanisms of Cystoid Macular Edema, Ophthalmic Research, vol.36, issue.5, pp.241-250, 2004.
DOI : 10.1159/000081203

A. Ossewaarde-van-norel and A. Rothova, Clinical Review: Update on Treatment of Inflammatory Macular Edema, Ocular Immunology and Inflammation, vol.224, issue.6, pp.75-83, 2011.
DOI : 10.1080/09273940701244509

A. Reichenbach, A. Wurm, T. Pannicke, I. Iandiev, P. Wiedemann et al., M??ller cells as players in retinal degeneration and edema, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.6, issue.5, pp.627-663, 2007.
DOI : 10.1007/s00417-006-0516-y

Y. Guex-crosier, The pathogenesis and clinical presentation of macular edema in inflammatory diseases, Doc Ophthalmol Adv Ophthalmol, vol.97, pp.3-4297, 1999.
DOI : 10.1007/978-94-011-4152-9_10

T. Wolfensberger and Z. Gregor, Macular Edema ??? Rationale for Therapy, Dev Ophthalmol, vol.47, pp.49-58, 2010.
DOI : 10.1159/000320073

B. Van-kooij, K. Probst, R. Fijnheer, M. Roest, W. De-loos et al., Risk factors for cystoid macular oedema in patients with uveitis, Eye, vol.8, issue.2, pp.256-60, 2008.
DOI : 10.1038/sj.eye.6702595

R. Karim, E. Sykakis, S. Lightman, and S. Fraser-bell, Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis, Clinical Ophthalmology, vol.7, pp.1109-1153, 2013.
DOI : 10.2147/OPTH.S40268

V. Sarao, D. Veritti, F. Boscia, and P. Lanzetta, Intravitreal Steroids for the Treatment of Retinal Diseases, The Scientific World Journal, vol.31, issue.6, p.989501, 2014.
DOI : 10.1097/IAE.0b013e318188c814

W. Kiddee, G. Trope, L. Sheng, L. Beltran-agullo, M. Smith et al., Intraocular Pressure Monitoring Post Intravitreal Steroids: A Systematic Review, Survey of Ophthalmology, vol.58, issue.4, pp.291-310, 2013.
DOI : 10.1016/j.survophthal.2012.08.003

R. Hunter and A. Lobo, Dexamethasone intravitreal implant for the treatment of noninfectious uveitis, Clin Ophthalmol Auckl NZ, vol.5, pp.1613-1634, 2011.

A. Thakur, R. Kadam, and U. Kompella, Trabecular Meshwork and Lens Partitioning of Corticosteroids, Archives of Ophthalmology, vol.129, issue.7, pp.914-934, 2011.
DOI : 10.1001/archophthalmol.2011.39

C. Stahn and F. Buttgereit, Genomic and nongenomic effects of glucocorticoids, Nature Clinical Practice Rheumatology, vol.149, issue.10, pp.525-558, 2008.
DOI : 10.1038/ncprheum0898

N. Miyamoto, D. Iossifov, F. Metge, and F. Behar-cohen, Early Effects of Intravitreal Triamcinolone on Macular Edema, Ophthalmology, vol.113, issue.11, 2006.
DOI : 10.1016/j.ophtha.2006.05.037

R. Herrero-vanrell, J. Cardillo, and B. Kuppermann, Clinical applications of the sustainedrelease dexamethasone implant for treatment of macular edema, Clin Ophthalmol Auckl NZ, vol.5, pp.139-185, 2011.

A. Sallam, H. Sheth, Z. Habot-wilner, and S. Lightman, Outcome of Raised Intraocular Pressure in Uveitic Eyes with and without a Corticosteroid-Induced Hypertensive Response, American Journal of Ophthalmology, vol.148, issue.2
DOI : 10.1016/j.ajo.2009.02.032

M. Inoue, K. Takeda, K. Morita, M. Yamada, Y. Tanigawara et al., Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection, American Journal of Ophthalmology, vol.138, issue.6, pp.1046-1054, 2004.
DOI : 10.1016/j.ajo.2004.05.028

S. Taylor, H. Isa, L. Joshi, and S. Lightman, New Developments in Corticosteroid Therapy for Uveitis, Ophthalmologica, vol.224, issue.1, pp.46-53, 2010.
DOI : 10.1159/000318021

J. Curtis, Y. Kim, T. Bryant, A. J. Scott, D. Saag et al., Osteoporosis in the home health care setting: A window of opportunity? Arthritis Rheum, pp.971-976, 2006.

Y. Byun and Y. Park, Complications and Safety Profile of Posterior Subtenon Injection of Triamcinolone Acetonide, Journal of Ocular Pharmacology and Therapeutics, vol.25, issue.2, pp.159-62, 2009.
DOI : 10.1089/jop.2008.0087

H. Kok, C. Lau, N. Maycock, P. Mccluskey, and S. Lightman, Outcome of Intravitreal Triamcinolone in Uveitis, Ophthalmology, vol.112, issue.11, pp.1916-1917, 2005.
DOI : 10.1016/j.ophtha.2005.06.009

A. Sallam, S. Taylor, and S. Lightman, Review and update of intraocular therapy in noninfectious uveitis, Current Opinion in Ophthalmology, vol.22, issue.6, pp.517-539, 2011.
DOI : 10.1097/ICU.0b013e32834bbd68

D. Callanan, G. Jaffe, D. Martin, P. Pearson, and T. Comstock, Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results, Arch Ophthalmol, vol.126, issue.9, pp.1191-201, 2008.

S. Taylor, Z. Habot-wilner, P. Pacheco, and S. Lightman, Intraocular Methotrexate in the Treatment of Uveitis and Uveitic Cystoid Macular Edema, Ophthalmology, vol.116, issue.4, 2009.
DOI : 10.1016/j.ophtha.2008.10.033

B. Bodaghi, G. Gendron, B. Wechsler, C. Terrada, N. Cassoux et al., Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients, British Journal of Ophthalmology, vol.91, issue.3, pp.335-344, 2007.
DOI : 10.1136/bjo.2006.101550

A. Lasave, D. Zeballos, W. El-haig, M. Díaz-llopis, D. Salom et al., Short-term Results of a Single Intravitreal Bevacizumab (Avastin) Injection versus a Single Intravitreal Triamcinolone Acetonide (Kenacort) Injection for the Management of Refractory Noninfectious Uveitic Cystoid Macular Edema, Ocular Immunology and Inflammation, vol.114, issue.6, 2009.
DOI : 10.1016/S0161-6420(02)00975-2

J. Bae, C. Lee, and S. Lee, Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina Phila Pa, pp.111-119, 2011.

T. Missotten, J. Van-laar, T. Van-der-loos, P. Van-daele, R. Kuijpers et al., Octreotide Long-Acting Repeatable for the Treatment of Chronic Macular Edema in Uveitis, American Journal of Ophthalmology, vol.144, issue.6, pp.838-881, 2007.
DOI : 10.1016/j.ajo.2007.07.039

T. Liu, A. Hu, A. Kaines, F. Yu, S. Schwartz et al., A pilot study of normative data for macular thickness and volume measurements using cirrus high-definition optical coherence tomography. Retina Phila Pa, pp.1944-50, 2011.

J. Cao, M. Mulvalhill, L. Zhang, B. Joondeph, and M. Dacey, Dexamethasone Intravitreal Implant in the Treatment of Persistent Uveitic Macular Edema in the Absence of Active Inflammation. Ophthalmology, 2014.

E. Miserocchi, G. Modorati, M. Pastore, and F. Bandello, Dexamethasone Intravitreal Implant: An Effective Adjunctive Treatment for Recalcitrant Noninfectious Uveitis, Ophthalmologica, vol.228, issue.4, pp.229-262, 2012.
DOI : 10.1159/000343060

J. Myung, G. Aaker, and S. Kiss, Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant, Clin Ophthalmol Auckl NZ, vol.4, pp.1423-1429, 2010.

O. Tomkins-netzer, S. Taylor, A. Bar, A. Lula, S. Yaganti et al., Treatment with Repeat Dexamethasone Implants Results in Long-Term Disease Control in Eyes with Noninfectious Uveitis, Ophthalmology, vol.121, issue.8, pp.1649-54, 2014.
DOI : 10.1016/j.ophtha.2014.02.003

J. Zarranz-ventura, E. Carreño, R. Johnston, Q. Mohammed, A. Ross et al., Multicenter Study of Intravitreal Dexamethasone Implant in Noninfectious Uveitis: Indications, Outcomes, and Reinjection Frequency, American Journal of Ophthalmology, vol.158, issue.6, 2014.
DOI : 10.1016/j.ajo.2014.09.003

N. Sorkin, A. Loewenstein, Z. Habot-wilner, and M. Goldstein, Intravitreal Dexamethasone Implant in Patients with Persistent Macular Edema of Variable Etiologies, Ophthalmologica, vol.232, issue.2, pp.83-91, 2014.
DOI : 10.1159/000360304

DOI : 10.1097/IAE.0b013e31827e247b

D. Boyer, D. Faber, S. Gupta, S. Patel, H. Tabandeh et al., Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina Phila Pa, pp.915-938, 2011.

G. Williams, J. Haller, B. Kuppermann, M. Blumenkranz, D. Weinberg et al., Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome, American Journal of Ophthalmology, vol.147, issue.6, 2009.
DOI : 10.1016/j.ajo.2008.12.033

M. Bratton, Y. He, and D. Weakley, Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis, J AAPOS. 2014, vol.18, issue.2, pp.110-113

S. Bourgault, M. Aroichane, L. Wittenberg, A. Lavallée, and P. Ma, Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report, Journal of Ophthalmic Inflammation and Infection, vol.3, issue.1, p.61, 2013.
DOI : 10.1167/iovs.10-5285